E. M. ACTON
Impact in
-
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- Biophysics top 10%
- Electron Spin Resonance Studies
Papers in
-
- Carbohydrate Chemistry and Synthesis 3
- Synthesis and Biological Evaluation 2
- Synthesis and Characterization of Heterocyclic Compounds 2
-
- Cancer therapeutics and mechanisms 3
- Co-authors
- Lyn A. Mickley (1 shared paper)Jaulang Hwang (1 shared paper)Antonio Tito Fojo (1 shared paper)Robert A. Jensen (1 shared paper)H. Stone (3 shared papers)J.H. Peters (2 shared papers)David Streeter (1 shared paper)Kenneth J. Ryan (2 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (3 papers)Cellular and Molecular Life Sciences (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of the American Chemical Society (1 paper)Journal of Cardiovascular Pharmacology (1 paper)
- Partner nations
- United States
In The Last Decade
E. M. ACTON
14 papers receiving 375 citations
Peers
Comparison fields: 5 of 62
- Oncology 216
- Biophysics 39
- Cardiology and Cardiovascular Medicine 104
- Toxicology 12
- Nutrition and Dietetics 44
Countries citing papers authored by E. M. ACTON
This map shows the geographic impact of E. M. ACTON's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. ACTON with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. ACTON more than expected).
Fields of papers citing papers by E. M. ACTON
This network shows the impact of papers produced by E. M. ACTON. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. ACTON. The network helps show where E. M. ACTON may publish in the future.
Co-authors
The 23 scholars most cited alongside E. M. ACTON, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 178 | |
| 2 | 1984 | 87 | |
| 3 | 1985 | 36 | |
| 4 | 1976 | 25 | |
| 5 | 1980 | 17 | |
| 6 | 1970 | 14 | |
| 7 | 1978 | 8 | |
| 8 | 1987 | 6 | |
| 9 | Metabolic disposition of N,N-dibenzyldaunorubicin in the rat. | 1983 | 6 |
| 10 | 1979 | 5 | |
| 11 | 1953 | 4 | |
| 12 | 1968 | 3 | |
| 13 | 1989 | 2 | |
| 14 | 1982 | 1 | |
| 15 | 1985 | 1 |
About E. M. ACTON
E. M. ACTON is a scholar working on Organic Chemistry, Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology and Nutrition and Dietetics, having authored 15 papers that have together received 393 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Cancer therapeutics and mechanisms (3 papers), Carbohydrate Chemistry and Synthesis (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Biochemical Analysis and Sensing Techniques (2 papers), Analytical Chemistry and Chromatography (2 papers), Synthesis and Biological Evaluation (2 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Oncology (216 citations), Biophysics (39 citations), Cardiology and Cardiovascular Medicine (104 citations), Toxicology (12 citations) and Nutrition and Dietetics (44 citations). E. M. ACTON has collaborated with scholars based in United States. Frequent co-authors include Lyn A. Mickley, Jaulang Hwang, Antonio Tito Fojo, Robert A. Jensen, H. Stone, J.H. Peters, David Streeter, Kenneth J. Ryan, Richard A. Bernhard and L.F. Chuang. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Cellular and Molecular Life Sciences, Journal of Pharmacology and Experimental Therapeutics, Journal of the American Chemical Society and Journal of Cardiovascular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.